Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Aarcoron Aug 04, 2022 1:41pm
99 Views
Post# 34871624

RE:RE:RE:RE:RE:RE:August

RE:RE:RE:RE:RE:RE:AugustHi JD, I hope you're feeling well today.

Great posts yesterday !  One was talking about how management doesn't have the capability to monetize xb3 and the other was about challenging why management is not in a great negotiating position to moneitize xb3.  Hmmm....not sure what to make of all that.

Anyway, I gave you 100 reads and a thumbs up on each!!  All of the simps weighed in on the one about the latter, but a few of them neglected to thumbs up the one about management and ice cream - you might want to talk to them about that.

Have a great day !
<< Previous
Bullboard Posts
Next >>